ProCure HydroCerin 33 g/100g
Petrolatum 33% · CREAM · Twin Med LLC
ProCure HydroCerin is a cream containing petrolatum 33% at 33 g/100g, taken topical. Manufactured by Twin Med LLC.
Key Facts
- Brand Name
- ProCure HydroCerin
- Generic Name
- Petrolatum 33%
- NDC Code (Product)
55681-027- Manufacturer
- Twin Med LLC
- Strength
- 33 g/100g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- M016
- Marketing Start
- 09/15/2025
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses Uses: Temporarily protects minor: cuts, scrapes, and burns Temporarily protects and helps relieve chafed, chapped or cracked skin Helps prevent and protect from the drying effects of wind and cold weather
Dosage & Administration
Directions Directions Apply as needed
Warnings
Warnings Warnings For external use only When using this product When using this product do not get into the eyes Stop use and ask a doctor if Stop use and ask a doctor if Condition worsens Symptoms last more than 7 days or clear up and occur again within a few days Do not use on Do not use on deep or puncture wounds, animal bites, serious burns Keep out of reach of children Keep out of reach of children. In case of accidental ingestion contact a physician or Poison Control Center right away.
Frequently Asked Questions
What is ProCure HydroCerin used for?
ProCure HydroCerin contains Petrolatum 33%. It is a cream taken topical. Consult your doctor for specific uses.
Is ProCure HydroCerin a controlled substance?
ProCure HydroCerin is not classified as a controlled substance by the DEA.
What is the generic name for ProCure HydroCerin?
The generic name for ProCure HydroCerin is Petrolatum 33%. There are no other listed brand versions of Petrolatum 33%.
What is the NDC code for ProCure HydroCerin 33 g/100g?
The NDC (National Drug Code) for ProCure HydroCerin 33 g/100g is 55681-027, listed by Twin Med LLC.
Other ProCure HydroCerin Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)